CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 60 enrolled
Drug / intervention
Pred Forte +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00345046
NCT00345046Phase 4Completed
CompareCT.gov

A Comparison of Three Different Formulations of Topical Prednisolone Acetate 1% for Control of Post Glaucoma and/or Cataract Surgery Inflammation.

Indiana University·interventional·Posted Jun 27, 2006·Updated Jun 3, 2015

In Brief

A Phase 4 clinical trial evaluating Pred Forte, EconoPred Plus, and 1 other intervention for Glaucoma and Cataract. Completed, enrolled 60 participants across 1 site.

Detailed Summary

Generic prednisolone acetate 1% is less effective than Pred Forte 1% or Econopred Plus 1%.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma, Cataract
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 27, 2006
Enrollment StartSep 1, 2002
Primary CompletionSep 1, 2011
TodayJul 2, 2026
Enrollment to primary: 9 yearsPosted 20.0 years ago

Interventions

Pred Fortedrug

Four drops daily decreasing to once daily over four weeks.

EconoPred Plusdrug

Prednisolone Acetate four times daily decreasing to once daily over four weeks.

Prednisolone Acetatedrug

Dosed four times daily decreasing to once daily over four weeks.